Home > Events > Product launch readiness europe oct 2024

1 min read

Product Launch Readiness

Join Us for an Exclusive Conference on Product Launch Readiness - Lausanne, 24th October 2024, 17:00 CET

ADC Therapeutics, together with its partners Veristat, Supply Chain Operations, and PrimeTax, cordially invite you to here and exchange about:

“Product Launch Readiness: Key Cross-Functional Activities to Transition or Optimize Your Organization for Commercial Success”

About the event

In April 2021, Zynlonta™ received FDA approval in the US, followed by conditional marketing authorization in Europe in December 2022. This one-hour session will take you through ADC Therapeutics’ journey in preparing for the successful European launch of Zynlonta™, highlighting the importance of cross-functional expertise, coordinated teamwork, strategic partnerships, and careful planning.
With insights from ADC Therapeutics, Veristat, Supply Chain Operations, and PrimeTax, the event will explore critical milestones, challenges, and strategies to consider for launching any life sciences product and optimizing commercial operations.

Event Program

17:00 – Welcome
17:05 – Product Launch Readiness: Key Cross-Functional Activities to Transition or Optimize Your Organization for Commercial Success

Speakers

Gaspard Jouandon, Senior Director, Supply Chain Partner Management (exUS), ADC Therapeutics
Ausma Termanis, Associate Director Quality Assurance, Veristat
Tim Foetisch, VP Business Development, Supply Chain Operations
Dominic Nazareno, Partner, PrimeTax

17:45 - Q&A Session

18:00 - Apéritif, Snacks & Networking

20:00 - Event Conclusion

Why attend?

Gain firsthand insights into the complexities of launching a life sciences product. Learn from the Zynlonta™ success story and discover how to apply these lessons to your own projects. Plus, take advantage of the opportunity to network with industry professionals from ADC Therapeutics, Veristat, Supply Chain Operations, PrimeTax, and more during the networking session.

 

Event details:

  • When: Thursday, 24 October 2024, 17:00 – 20:00 CET
  • Where: Aquatis Hôtel, Route de Berne 148, 1010 Lausanne
If you have any questions, please feel free to contact delphine.guerin@veristat.com

We look forward to welcoming you and discussing how we can support your product launch and commercial optimization efforts.

 

 

 

 

 

Share This Event:

   

3 min read

Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works

When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...

3 min read

The Psychedelic Setback: What MDMA Rejection Taught Drug Developers

In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress disorder. The decision...